| 1 |
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon, Florian Strasser, Stefan D. Anker et al. · The Lancet Oncology
|
5 Feb 2011 |
5,828 |
| 2 |
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann Sebastian De Bono et al. · New England Journal of Medicine
Open access |
25 May 2011 |
4,448 |
| 3 |
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA
|
22 Oct 2003 |
2,547 |
| 4 |
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis G Paz-Ares et al. · The Lancet
246 authors |
4 Oct 2019 |
2,310 |
| 5 |
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al. · The Lancet Oncology
Open access |
19 Feb 2015 |
1,436 |
| 6 |
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Sapna Pradyuman Patel et al. · New England Journal of Medicine
Open access |
Mar 2023 |
893 |
| 7 |
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
Jonathan Wade Goldman et al. · The Lancet Oncology
Open access253 authors |
4 Dec 2020 |
707 |
| 8 |
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
Adrianus Johannes De Langen et al. · The Lancet
Open access |
7 Feb 2023 |
609 |
| 9 |
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Zev A. Wainberg, Davide Melisi, Teresa Mercade Macarulla et al. · The Lancet
Open access |
11 Sep 2023 |
504 |
| 10 |
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
Hordur Mar Kolbeinsson, Sreenivasa Rao Chandana, Gerald Paul Wright et al. · Journal of Investigative Surgery
Open access |
3 Oct 2022 |
395 |
| 11 |
Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs
Nancy M. Petry et al. · Archives of General Psychiatry
|
Oct 2005 |
377 |
| 12 |
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN
Luis G Paz-Ares et al. · ESMO Open
Open access |
10 Mar 2022 |
349 |
| 13 |
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline
Susan S. Jacobs et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
Nov 2020 |
319 |
| 14 |
Effects of Lower-Cost Incentives on Stimulant Abstinence in Methadone Maintenance Treatment
Jessica M. Peirce, Nancy M. Petry, Maxine L. Stitzer et al. · Archives of General Psychiatry
|
Feb 2006 |
310 |
| 15 |
Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy
David H. Henry, Naomi V. Dahl, Michael Auerbach et al. · The Oncologist
Open access |
Feb 2007 |
268 |
| 16 |
A Study on Breath Acetone in Diabetic Patients Using a Cavity Ringdown Breath Analyzer: Exploring Correlations of Breath Acetone With Blood Glucose and Glycohemoglobin A1C
Chuji Wang, Armstrong Mbi, Mark D. Shepherd · IEEE Sensors Journal
|
11 Dec 2009 |
235 |
| 17 |
Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131 I: Practice Recommendations of the American Thyroid Association
John E. Freitas, Iain Ross McDougall, Lawrence T. Dauer et al. · Thyroid
Open access |
18 Mar 2011 |
234 |
| 18 |
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial
Hope S. Rugo, Lasika C. Seneviratne, Joseph Thaddeus Beck et al. · The Lancet Oncology
|
14 Mar 2017 |
230 |
| 19 |
Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
John Y. M. Koo, Lauren B. Marangell, Masaru Nakamura et al. · Journal of the European Academy of Dermatology and Venereology
|
6 Jul 2017 |
209 |
| 20 |
7 Intention to Treat in Clinical Trials
Lloyd D. Fisher, Dennis O. Dixon, Jay Herson et al.
Book chapter |
19 Sep 2017 |
205 |
| 21 |
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Anish Thomas et al. · Journal of Thoracic Oncology
Open access |
8 May 2019 |
187 |
| 22 |
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
Mark Lebwohl, Kim Alexander Papp, Lauren B. Marangell et al. · Journal of the American Academy of Dermatology
|
3 Oct 2017 |
181 |
| 23 |
Cooperative Regulation of Mcl-1 by Janus Kinase/STAT and Phosphatidylinositol 3-Kinase Contribute to Granulocyte-Macrophage Colony-Stimulating Factor-Delayed Apoptosis in Human Neutrophils
Pearlie K. Epling‐Burnette, Bin Zhong, Fanqi Bai et al. · The Journal of Immunology
|
Jun 2001 |
179 |
| 24 |
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
Jørn Herrstedt et al. · ESMO Open
Open access |
11 Jan 2024 |
175 |
| 25 |
Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
Aurelius Gabriel Omlin, David E. Blum, Jan Wierecky et al. · Journal of Cachexia Sarcopenia and Muscle
Open access |
10 Jan 2013 |
160 |
| 26 |
Transplant Nephrectomy Improves Survival following a Failed Renal Allograft
Juan Carlos Ayus, Steven G. Achinger, Shuko Lee et al. · Journal of the American Society of Nephrology
Open access |
29 Oct 2009 |
147 |
| 27 |
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action
Charles P. O’Brien et al. · Biological Psychiatry
|
Nov 2004 |
142 |
| 28 |
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer
Rona D. Yaeger, Nataliya Volodymyrivna Uboha, Meredith S. Pelster et al. · Cancer Discovery
Open access |
8 Apr 2024 |
133 |
| 29 |
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
Melinda E. Sanders, Peggy A. Schuyler, Jean F. Simpson et al. · Modern Pathology
Open access |
12 Dec 2014 |
132 |
| 30 |
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup
Michael W Retsky, Rick A. Rogers, Romano Demicheli et al. · Breast Cancer Research and Treatment
Open access |
23 May 2012 |
126 |
| 31 |
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine
Joseph A. Kwentus, Robert A. Riesenberg, Morteza Marandi et al. · Bipolar Disorders
|
Feb 2012 |
126 |
| 32 |
Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia
Gary M. Ansel, Nancy S. Sample, Charles F. Botti et al. · Catheterization and Cardiovascular Interventions
|
18 Dec 2003 |
125 |
| 33 |
Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
Michael W Retsky, Romano Demicheli, William J.M. Hrushesky et al. · Current Medicinal Chemistry
Open access |
Sep 2013 |
122 |
| 34 |
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models
Delphine Lissa, Nobuyuki Takahashi, Parth Anil Desai et al. · Nature Communications
Open access |
19 Apr 2022 |
118 |
| 35 |
NuCLS: A scalable crowdsourcing approach and dataset for nucleus classification and segmentation in breast cancer
Mohamed T. Amgad et al. · GigaScience
Open access |
2022 |
114 |
| 36 |
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Sreenivasa Rao Chandana, Hani M. Babiker, Daruka Mahadevan · Expert Opinion on Investigational Drugs
|
12 Dec 2018 |
110 |
| 37 |
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
Ryan James Hartmaier et al. · Annals of Oncology
Open access |
18 Jan 2018 |
110 |
| 38 |
Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
Johanna C. Bendell, John J. Nemunaitis, Sasha J. Vukelja et al. · Journal of Clinical Oncology
Open access |
4 Oct 2011 |
107 |
| 39 |
Mechanical Evaluation of Cross-Link Designs in Rigid Pedicle Screw Systems
Jeffrey C. Dick, Thomas A. Zdeblick, Brian D. Bartel et al. · Spine
|
Feb 1997 |
100 |
| 40 |
Eccentricity pacing of eastern equatorial Pacific carbonate dissolution cycles during the Miocene Climatic Optimum
Karlos Guilherme Diemer Kochhann, Ann Holbourn, Wolfgang Kuhnt et al. · Paleoceanography
|
22 Aug 2016 |
94 |
| 41 |
A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma
Devalingam Mahalingam, Julio Peguero, Putao Cen et al. · Cancers
Open access |
17 Jun 2019 |
92 |
| 42 |
Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
Robert F. Forman, Dace S. Svikis, Iván D. Montoya et al. · Journal of Substance Abuse Treatment
Open access |
29 Jun 2004 |
90 |
| 43 |
Epidemiology of mental health comorbidity in psoriasis
Jashin J. Wu, Steven R. Feldman, John Y. M. Koo et al. · Journal of Dermatological Treatment
|
21 Oct 2017 |
89 |
| 44 |
Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer Center
Douglas W. Blayney, Kristen K. McNiff, David A. Hanauer et al. · Journal of Clinical Oncology
Open access |
2 Jun 2009 |
88 |
| 45 |
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma
Begoña Comı́n-Anduix, Yohan Lee, Jason Jalil et al. · Journal of Translational Medicine
Open access |
May 2008 |
82 |
| 46 |
Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models
Jae Hun Shin, Hyung Bae Park, Yu Mi Oh et al. · Blood
|
27 Apr 2012 |
82 |
| 47 |
Percutaneous Retrograde Tibial Access in Limb Salvage
Charles F. Botti, Gary M. Ansel, Mitchell Silver et al. · Journal of Endovascular Therapy
Open access |
Jun 2003 |
80 |
| 48 |
Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies
Gerald Steven Falchook et al. · Clinical Cancer Research
|
16 Sep 2019 |
79 |
| 49 |
Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults
Kathleen M. Mullane, Drew J. Winston, Michael S. Wertheim et al. · The Journal of Infectious Diseases
|
Aug 2013 |
78 |
| 50 |
Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies.
C. Harris Spiridonidis, Leslie Rogers Laufman, J. B. Jones et al. · Journal of Clinical Oncology
|
Dec 1998 |
72 |